ArticleCancers2024

Profiling Plasma Extracellular Vesicle Metabotypes and miRNAs: An Unobserved Clue for Predicting Relapse in Patients with Early-Stage NSCLC.

Vivi Bafiti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.